World ADC Awards

Celebrating 11 Years of Recognizing the Top Calibre, Achievement & Influence in ADC Development

Taking place during the World ADC San Diego conference, the World ADC Awards ceremony serves as a great opportunity to recognize recent successes, long-term commitment to the field and upcoming pioneers who have gone above and beyond to ensure the continued success of this field.

Our 11th Anniversary celebrations will be unforgettable and our biggest and better yet, as we will recognized amazing individual work, extraordinary endeavors, teamwork, and commercial acumen across 10 categories.

With 1000+ votes to be cast and many scientific proposals to be drafted, our expert judging panel will reach an agreement on all of our winners and runners up for 2024.

“The 2024 World ADC Awards is a special evening to celebrate individual and company successes, as well as the hard work that those across the field are doing on a daily basis. After commemorating our 10-year anniversary last year, the 2024 celebrations will be particularly special as we recognize the trailblazers of the ADC field. We are delighted to see the quality of research and caliber of nominations, mirroring the recent progress we are seeing across the entire industry right now!”

Thomas Cosgrove, Brand Director, World ADC San Diego


2024 Judges to Be Announced

2023 Judges

Greg Thurber

Senior Principal Scientist

University of Michigan

Ian Schwartz

Director, Bioconjugation Process Development


Jagath Reddy Junutula

President & Chief Executive Officer

Aarvik Therapeutics

John Lambert


Attager Consulting

Gail Lewis

Senior Principal Scientist


Puja Sapra

Vice President, Head of Tumor Targeted Delivery, Oncology R&D


Rakesh Dixit

President & CEO


Robert Lutz

Chief Science Officer

Iksuda Therapeutics

2023 Memorable Highlights

ADC Awards-12
ADC Awards-82 (1) (1)
ADC Awards-56 (1) (1)

2023 Award Winners


Best ADC Platform Technology

Winner: LegoChem Biosciences
Runner-Up: Catalent SMARTag Technology
Abzena, Ajinomoto Bio-Pharma Services, Genequantum Healthcare, WuXi XDC, Synaffix

Most Promising Clinical Candidate

Winner: Enfortumab vedotin (PADCEV) – Seagen/Astellas
Runners Up:
BL-B01D1 – SystImmune, Patritumab deruxtecan - Daiichi Sankyo
ARX788 – Ambrx, Datopotamabderuxtecan – AstraZeneca / Daiichi Sankyo, Farletuzumab Ecteribulin – Eisai / Bristol Myers-Squibb, Ziloveramabvedotin - Merck & Co.

Best New Drug Developer

 Winner: Exelixis
Runner Up: Duality Biologics
Shortlisted: Ambrx, Eisai, Genequantum Healthcare, Iksuda Therapeutics

Best Contract Research Organization

Winners: NJ Bio, Inc. & Charles River Laboratories
Abzena, ChemExpress, Eurofins, PPD, Pharmaron, Sterling Pharma Solutions

Best Contract Manufacturing Development Organization

Winner: WuXi XDC
Runners Up: Lonza, BSP Pharmaceuticals
Shortlisted: Axplora, MilliporeSigma, Piramal Pharma Solutions

Best ADC Preclinical Publication 2022

Winner: Discovery of BT8009: A Nectin-4
Targeting Bicycle Toxin Conjugate for the Treatment of Cancer
Runner Up: Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian Cancer

Best ADC Clinical Publication 2022

Winner: Trastuzumab deruxtecan in Previously Treated HER2-Positive Breast Cancer
Runner Up: Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer

Outstanding Academic Investigator Award

Winner: Nathan Tumey, Binghampton University

The George R Pettit Individual Input to the Field Award

Winner: Dr. Shanu Modi, Memorial Sloan Kettering Cancer Center

Long-Standing Contribution to the Field Award

Winner: Puja Sapra


Each year, during the World ADC Awards’s team alongside a panel of independent judges select scientists, researchers, and drug developers who are progressing ADCs to the front-line as life changing treatments for those patients diagnosed with cancer.

For more information about World ADC San Diego and the World ADC Awards please visit: and

Sponsorship Opportunities

Partner with the World ADC Awards in recognizing leaders and visionaries who are being recognized by industry experts for their innovations, services, and dedication to the ADC field.

From promotion and brand awareness to networking opportunities and increased reputation, being an ADC Award sponsor has many benefits that you may not have even thought of.

The World ADC team ploughs its collective energy in to sourcing the insights you need. We investigate the most challenging problems facing the industry; source the leading experts who have game-changing solutions; and distil this into accessible formats of information exchange – for you. From globally leading conferences to webinars and industry reports, whatever the information you need, World ADC can offer you the insights you need to accelerate your ADC programs.

The value World ADC provides you is the power of insight and connections. Not artificial, and not short-lived. We nurture the right environments in which people can communicate problems and solutions; share novel data and forge networks across the industry that will make each of your endeavours more informed and more robust.

We share a common belief with the industry – that the potential of antibody drug conjugates is enormous. In the war against cancer, ADCs can be a game-changer and we know that the right insights and connections can sharpen the weapons that are in your arsenal.

Join us at the heart of the ADC community to improve your programmes and be part of the mission to develop better antibody drug conjugate drugs.